Vawter Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.23M Hold
1,860
0.84% 27
2026
Q1
$1.71M Sell
1,860
-10
-0.5% -$10.1K 0.72% 32
2025
Q4
$2.01M Buy
1,870
+2
+0.1% +$1.91K 0.85% 27
2025
Q3
$1.43M Buy
+1,868
New +$1.39M 0.65% 33
2025
Q2
Sell
-1,877
Closed -$1.55M 71
2025
Q1
$1.55M Buy
1,877
+9
+0.5% +$7.49K 0.87% 30
2024
Q4
$1.44M Buy
1,868
+7
+0.4% +$5.8K 0.87% 29
2024
Q3
$1.65M Buy
1,861
+100
+6% +$89.9K 1.01% 26
2024
Q2
$1.59M Buy
1,761
+10
+0.6% +$8K 1.09% 23
2024
Q1
$1.36M Hold
1,751
0.99% 22
2023
Q4
$1.02M Buy
1,751
+27
+2% +$15.8K 0.8% 24
2023
Q3
$926K Hold
1,724
1.05% 22
2023
Q2
$809K Buy
+1,724
New +$723K 0.7% 27

Other funds holding LLY

Vawter Financial's LLY Position: Q2 2026 in Review

Vawter Financial held its Eli Lilly (LLY) position steady in Q2 2026 at 1,860 shares worth $2.23M. The position accounts for 0.84% of the portfolio, ranked #27.

Vawter Financial first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vawter Financial held 1,860 shares of Eli Lilly worth $2.23M as of Q2 2026.
  • Vawter Financial left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.84% of Vawter Financial's portfolio in Q2 2026, its #27 holding.
  • Vawter Financial first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vawter Financial's 13F filing for Q2 2026, filed 24 Jul 2026.